Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

On the road with Henry Lynch.

Hereditary cancer in clinical practice·2020
Same author

Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes.

Nature genetics·2020
Same author

Serum selenium level and cancer risk: a nested case-control study.

Hereditary cancer in clinical practice·2020
Same author

Late Recurrences After Estrogen Receptor-Positive Breast Cancer.

JAMA oncology·2019
Same author

Retesting of women who are negative for a <i>BRCA1</i> and <i>BRCA2</i> mutation using a 20-gene panel.

Journal of medical genetics·2019
Same author

Exome Sequencing in <i>BRCA1-</i> and <i>BRCA2</i>-Negative Greek Families Identifies <i>MDM1</i> and <i>NBEAL1</i> as Candidate Risk Genes for Hereditary Breast Cancer.

Frontiers in genetics·2019

Related Experiment Video

Updated: Jul 14, 2026

Identifying the Effects of BRCA1 Mutations on Homologous Recombination using Cells that Express Endogenous Wild-type BRCA1
08:53

Identifying the Effects of BRCA1 Mutations on Homologous Recombination using Cells that Express Endogenous Wild-type BRCA1

Published on: February 17, 2011

BRCA1 and BRCA2: 1994 and beyond.

Steven A Narod1, William D Foulkes

  • 1Centre for Research on Women's Health, Sunnybrook and Womens College Health Sciences Center, 790 Bay Street, Toronto, Ontario M5G 1N8, Canada. steven.narod@sw.ca

Nature Reviews. Cancer
|September 3, 2004
PubMed
Summary

The discovery of the BRCA1 gene advanced understanding of hereditary breast cancer, its epidemiology, and DNA repair roles. However, translating this knowledge into effective new treatments remains a significant challenge.

Area of Science:

  • Oncology
  • Genetics
  • Epidemiology

Background:

  • The identification of the BRCA1 gene was expected to significantly advance breast cancer research.
  • Decades of research have illuminated the genetic epidemiology of breast cancer.
  • Understanding of BRCA1 and BRCA2 mutations, their ethnic variations, and clinical impacts has grown substantially.

Purpose of the Study:

  • To review the advancements in understanding hereditary breast cancer since the discovery of BRCA1.
  • To assess the translation of genetic discoveries into clinical applications for breast cancer.
  • To highlight the role of DNA repair in breast cancer susceptibility.

Main Methods:

  • Literature review of genetic epidemiology studies.
  • Analysis of data on BRCA1 and BRCA2 mutation frequencies and consequences.

More Related Videos

gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of BRCA1, BRCA2, and 9 Genes Involved in DNA Damage Repair
08:15

gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of BRCA1, BRCA2, and 9 Genes Involved in DNA Damage Repair

Published on: October 6, 2014

Silencing of BRCA2 to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells
09:24

Silencing of BRCA2 to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells

Published on: August 12, 2015

Related Experiment Videos

Last Updated: Jul 14, 2026

Identifying the Effects of BRCA1 Mutations on Homologous Recombination using Cells that Express Endogenous Wild-type BRCA1
08:53

Identifying the Effects of BRCA1 Mutations on Homologous Recombination using Cells that Express Endogenous Wild-type BRCA1

Published on: February 17, 2011

gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of BRCA1, BRCA2, and 9 Genes Involved in DNA Damage Repair
08:15

gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of BRCA1, BRCA2, and 9 Genes Involved in DNA Damage Repair

Published on: October 6, 2014

Silencing of BRCA2 to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells
09:24

Silencing of BRCA2 to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells

Published on: August 12, 2015

  • Synthesis of research on DNA repair mechanisms in cancer susceptibility.

    • Main Results:

    • Significant progress has been made in understanding the genetic epidemiology of breast cancer.
    • The distribution and clinical effects of BRCA1 and BRCA2 mutations are better understood.
    • The critical role of DNA repair in breast cancer susceptibility is established.

    Conclusions:

    • While knowledge of hereditary breast cancer genetics has expanded, clinical breakthroughs in treatment remain limited.
    • Further research is needed to bridge the gap between genetic discoveries and therapeutic applications.
    • The clinical translation of genetic insights into novel breast cancer therapies is an ongoing challenge.